secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2022-05-31T23:59:59+00:00
Accession:  0001171843-22-004019
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Compass Therapeutics stockholders elect directors and ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Philip J. Ferneau re-elected with 57.0M votes for, 8.5M withheld; Carl L. Gordon with 55.5M for, 10.0M withheld.
- Ratification of CohnReznick LLP as auditor for FY 2022 passed with 82.3M for, 65,654 against, 5,702 abstain.
- No other proposals or material changes disclosed at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000117184322004019/0001171843-22-004019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000117184322004019/f8k_053122.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-004019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer